globalnews.ca
46%
431
Vancouver biotech firm could play key role in developing COVID-19 vaccine
COVID-19 vaccines to market.Acuitas Therapeutics is currently partnering with three teams, including one backed by drug giant Pfizer and one out of Imperial College London, who have entered Phase I/II clinical vaccine trials.BioNTech, which has partnered with Pfizer, began its trials back in April, while CureVac and Imperial College began trials last month.